APA
Manning J., Vanachayangkul P., Lon C., Spring M., So M., Sea D., Se Y., Somethy S., Phann S., Chann S., Sriwichai S., Buathong N., Kuntawunginn W., Mitprasat M., Siripokasupkul R., Teja-Isavadharm P., Soh E., Timmermans A., Lanteri C., Kaewkungwal J., Auayporn M., Tang D., Chour C. M., Prom S., Haigney M., Cantilena L. & Saunders D. (20150520). Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval. : Antimicrobial agents and chemotherapy.
Chicago
Manning Jessica, Vanachayangkul Pattaraporn, Lon Chanthap, Spring Michele, So Mary, Sea Darapiseth, Se Youry, Somethy Sok, Phann Sut-Thang, Chann Soklyda, Sriwichai Sabaithip, Buathong Nillawan, Kuntawunginn Worachet, Mitprasat Mashamon, Siripokasupkul Raveewan, Teja-Isavadharm Paktiya, Soh Eugene, Timmermans Ans, Lanteri Charlotte, Kaewkungwal Jaranit, Auayporn Montida, Tang Douglas, Chour Char Meng, Prom Satharath, Haigney Mark, Cantilena Louis and Saunders David. 20150520. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval. : Antimicrobial agents and chemotherapy.
Harvard
Manning J., Vanachayangkul P., Lon C., Spring M., So M., Sea D., Se Y., Somethy S., Phann S., Chann S., Sriwichai S., Buathong N., Kuntawunginn W., Mitprasat M., Siripokasupkul R., Teja-Isavadharm P., Soh E., Timmermans A., Lanteri C., Kaewkungwal J., Auayporn M., Tang D., Chour C. M., Prom S., Haigney M., Cantilena L. and Saunders D. (20150520). Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval. : Antimicrobial agents and chemotherapy.
MLA
Manning Jessica, Vanachayangkul Pattaraporn, Lon Chanthap, Spring Michele, So Mary, Sea Darapiseth, Se Youry, Somethy Sok, Phann Sut-Thang, Chann Soklyda, Sriwichai Sabaithip, Buathong Nillawan, Kuntawunginn Worachet, Mitprasat Mashamon, Siripokasupkul Raveewan, Teja-Isavadharm Paktiya, Soh Eugene, Timmermans Ans, Lanteri Charlotte, Kaewkungwal Jaranit, Auayporn Montida, Tang Douglas, Chour Char Meng, Prom Satharath, Haigney Mark, Cantilena Louis and Saunders David. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval. : Antimicrobial agents and chemotherapy. 20150520.